Navigation Links
Medrio, a Leading EDC Provider for Clinical Research, Announces Its Latest Version, 8.1 with iPad Support, is Available Without Charge for Academic Researchers
Date:7/10/2013

hensive solution. Additionally, given their support and responsiveness it's astounding they are free," said Troy Hamilton, Clinical Research Manager Division of Nephrology at the University of Calgary.

About Medrio, Inc.
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Medrio is available free for investigator initiated studies that are university and/or government funded. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information, visit scholars.medrio.com to learn more about Medrio’s Scholars program.

Read the full story at http://www.prweb.com/releases/eClinicalsoftware/SaaS/prweb10823158.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Announces the Highly Anticipated Release of Medrio 8.1 with iPad Support
2. Accel-KKR Makes Growth Equity Investment in Zinc Ahead, Leading Provider of Marketing Compliance Solutions for the Life Sciences Industry
3. Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes
4. Metabolix Executives to Present at Leading Industry Conferences
5. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
6. Alexandrias 499 Illinois Street in Mission Bay, San Francisco, Signs Anchor 97,700 Rentable Square Foot Lease with Leading Mid-Cap Life Science Company
7. Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013
8. Safe Non-Toxic Enzyme Cleaner Replaces Bleach as Leading Mold & Flood Cleaning Solution
9. PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy
10. Tata Partners with Tel Aviv University to Fund Leading Edge Innovations for Accelerated Commercialization
11. PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Research and Markets ... the "Analysis of the Global Flow Cytometry ... Globally, flow cytometry remains a popular tool ... and stem cells. But the market is witnessing ... demand from underdeveloped nations to quantitate CD4 cell ...
(Date:7/28/2015)... 28, 2015 Deerfield Management Company, L.P. today ... L.P., which will invest in groundbreaking advancements in science ... cancer, and orphan diseases. The venture capital fund will ... are developed and improve the way healthcare is delivered ... largest healthcare-focused venture funds in the sector, will donate ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix Inc. ... 1 clinical trial with MMI-0100, a first-in-class inhibitor ... developed for pulmonary disorders characterized by inflammation and ... United Kingdom , is a double-blind, two-way ... the safety and tolerability of MMI-0100 when given ...
(Date:7/28/2015)... CITY , July 28, 2015 /PRNewswire/ - Aeterna ... today announced that it has granted to German ... funding the development and commercialization of biotechnology (collectively, ... live recombinant oral allogenic tumor vaccine technology (the ... for prostate cancer which is ready to enter ...
Breaking Biology Technology:Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3
... Child Should Die of Diabetes, BRUSSELS, October 13 ... is bringing together key opinion,leaders to push for action ... in developing countries without access to care., The ... the,Developing World, will be held on Saturday, October 25 ...
... discoveries add to understanding of individual risk of ... personal genome,analysis scan, REYKJAVIK, Iceland, Oct. 13 ... today report the discovery of common,versions of two ... risk of basal cell carcinoma (BCC), the most ...
... appropriateness of durable pain palliation as a primary ... endpoint for product marketing approval, ... BOTHELL, WA and VANCOUVER, Oct. 13 /PRNewswire-FirstCall/ - OncoGenex,Pharmaceuticals Inc. (NASDAQ: ... U.S. Food and Drug Administration (FDA) on October 7,2008, and that ...
Cached Biology Technology:International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer 2deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer 3deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer 4OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011 2OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011 3OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011 4
(Date:6/24/2015)... June 22, 2015 ... addition of the "Huawei Ascend Mate 7 ... to their offering. Huawei,s technological choice ... opposite direction than Apple,s and Samsung,s one. The ... developed by Fingerprint Cards, a main actor in ...
(Date:6/23/2015)... June 23, 2015   MedNet Solutions , ... the entire spectrum of clinical research, is pleased ... ™ , the company,s intuitive, flexible and affordable ... Silver 2015 Stevie® Award by the American ... Services Website category.  The American Business Awards are ...
(Date:6/23/2015)... , June 23, 2015   Valencell, ... announced the results of a recent study that ... on the wrist during activity. In a study ... was compared along with the Apple Watch against ... measuring heart rate during activity. The study demonstrated ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... from the Global Carbon Project and CSIRO Marine and Atmospheric ... releases 1.5 billion tonnes of carbon each year into the ... 20 per cent of carbon emissions due to human activities," ... 130 billion tonnes of carbon by 2100, which is greater ...
... more than 110,000 chemical substances which have been generated ... than 2,000 new substances, most of them contaminants, which ... present in food, air, soil and water. Nonetheless, human ... (what is known in this scientific field as "inadvertent ...
... are doing -- she's feeding herself, putting on her own ... describing her daughter Dave'yana, who will turn three in September, ... at Duke University Medical Center in April 2005 to reconstitute ... receive such a transplant at Duke to correct immune system ...
Cached Biology News:Confirmed -- deforestation plays critical climate change role 2100 percent of pregnant women have at least one kind of pesticide in their placenta 2100 percent of pregnant women have at least one kind of pesticide in their placenta 3Thymus transplants gives hope to babies with fatal immune disease 2Thymus transplants gives hope to babies with fatal immune disease 3
...
in vitro Translation, Accessory Products...
... The GenoStat Inducible Expression System provides ... in mammalian cells and is capable of ... control is mediated by the highly specific ... chimeric bipartite nuclear receptor complex. Gene expression ...
Mouse Aminopeptidase P2/XPNPEP2 Biotinylated Aff Pur PAb Keywords: AminopeptidaseP2, Metalloproteinase, Metalloprotease, X-Prolyl Aminopeptidase 2, X-Pro Aminopeptidase 2, Membrane-bound Prote...
Biology Products: